Artificial Intelligence from ScreenPoint Medical and Volpara Health Demonstrates Ability to Predict Long-Term Breast Cancer Risk

Research from Mayo Clinic and UCSF find that the combination of Transpara ® Exam Score with Volpara TruDensity® can predict long-term risk of invasive breast cancers NIJMEGEN, Netherlands

Related Keywords

New Zealand ,Nijmegen ,Gelderland ,Netherlands ,California ,United States ,San Francisco ,Wellington ,New Zealand General ,Ralph Highnam ,Gewinn Nur ,Nico Karssemeijer ,Volpara Trudensity ,Radboud University ,University Of California ,Volpara Health ,Mayo Clinic ,Exam Score ,Artificial Intelligence System ,Volumetric Density ,Risk Prediction ,Advanced Breast Cancer ,Low Risk ,Professor Nico Karssemeijer ,Chief Scientific Officer ,Screenpoint Medical ,Chief Science ,Innovation Officer ,Point Medical ,Artificial ,Intelligence ,Rom ,Screenpoint ,Medical ,Volpara ,Health ,Emonstrates ,Ability ,Redict ,Song ,Term ,Breast ,Dancer ,Risk ,